ANN ARBOR, Mich., Oct. 27, 2010 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading developer of expanded autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced that Tim Mayleben, president and CEO, will present on behalf of the company at the 21st Annual Oppenheimer Healthcare Conference, to be held at the Waldorf-Astoria in New York City from November 2-3, 2010.
